These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 32285309

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility.
    Tomoto K, Fujimoto A, Inenaga C, Okanishi T, Imai S, Ogai M, Fukunaga A, Nakamura H, Sato K, Obana A, Masui T, Arai Y, Enoki H.
    BMC Neurol; 2021 Mar 31; 21(1):139. PubMed ID: 33784976
    [Abstract] [Full Text] [Related]

  • 3. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.
    Katz JS, Frankel H, Ma T, Zagzag D, Liechty B, Zeev BB, Tzadok M, Devinsky O, Weiner HL, Roth J.
    Childs Nerv Syst; 2017 Apr 31; 33(4):601-607. PubMed ID: 28074282
    [Abstract] [Full Text] [Related]

  • 4. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
    Weidman DR, Pole JD, Bouffet E, Taylor MD, Bartels U.
    Pediatr Blood Cancer; 2015 Oct 31; 62(10):1754-60. PubMed ID: 25929843
    [Abstract] [Full Text] [Related]

  • 5. Presurgical Administration of mTOR Inhibitors in Patients with Large Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex.
    Jiang T, Du J, Raynald, Wang J, Li C.
    World Neurosurg; 2017 Nov 31; 107():1053.e1-1053.e6. PubMed ID: 28866062
    [Abstract] [Full Text] [Related]

  • 6. Association between the growth rate of subependymal giant cell astrocytoma and age in patients with tuberous sclerosis complex.
    Tsai JD, Wei CC, Tsao TF, Hsiao YP, Tsai HJ, Yang SH, Tsai ML, Sheu JN.
    Childs Nerv Syst; 2016 Jan 31; 32(1):89-95. PubMed ID: 26552385
    [Abstract] [Full Text] [Related]

  • 7. [Subependymal Giant Cell Astrocytoma with Tuberous Sclerosis Complex(TSC-SEGA)].
    Ichikawa T, Niida Y.
    No Shinkei Geka; 2022 Jan 31; 50(1):111-121. PubMed ID: 35169091
    [Abstract] [Full Text] [Related]

  • 8. Acute Management of Symptomatic Subependymal Giant Cell Astrocytoma With Everolimus.
    Arroyo MS, Krueger DA, Broomall E, Stevenson CB, Franz DN.
    Pediatr Neurol; 2017 Jul 31; 72():81-85. PubMed ID: 28511812
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA).
    Ebrahimi-Fakhari D, Franz DN.
    Expert Opin Pharmacother; 2020 Aug 31; 21(11):1329-1336. PubMed ID: 32338549
    [Abstract] [Full Text] [Related]

  • 10. [Response to everolimus in patients with giant cell astrocytoma associated to tuberous sclerosis complex].
    Mateos-González ME, López-Laso E, Vicente-Rueda J, Camino-León R, Fernández-Ramos JA, Baena-Gómez MA, Peña-Rosa MJ.
    Rev Neurol; 2014 Dec 01; 59(11):497-502. PubMed ID: 25418144
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations.
    Jóźwiak S, Nabbout R, Curatolo P, participants of the TSC Consensus Meeting for SEGA and Epilepsy Management.
    Eur J Paediatr Neurol; 2013 Jul 01; 17(4):348-52. PubMed ID: 23391693
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex.
    Cardamone M, Flanagan D, Mowat D, Kennedy SE, Chopra M, Lawson JA.
    J Pediatr; 2014 May 01; 164(5):1195-200. PubMed ID: 24518170
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Subependymal giant cell tumors in tuberous sclerosis complex.
    Goh S, Butler W, Thiele EA.
    Neurology; 2004 Oct 26; 63(8):1457-61. PubMed ID: 15505165
    [Abstract] [Full Text] [Related]

  • 19. The natural history of subependymal giant cell astrocytomas in tuberous sclerosis complex: a review.
    Chan DL, Calder T, Lawson JA, Mowat D, Kennedy SE.
    Rev Neurosci; 2018 Mar 28; 29(3):295-301. PubMed ID: 29211682
    [Abstract] [Full Text] [Related]

  • 20. Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review.
    Cobourn KD, Chesney KM, Mueller K, Fayed I, Tsering D, Keating RF.
    Childs Nerv Syst; 2024 Jan 28; 40(1):73-78. PubMed ID: 37658938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.